Potentially dangerous products that were recalled in 2023
Consumer safety regulators sounded the alarm about a range of products in 2023, including several geared to kids.
Kate Gibson is a Reporter for CBS MoneyWatch in New York, where she covers business and consumer finance. She previously worked for CNBC and MarketWatch and has written for national news outlets, including Barron's, the Wall Street Journal and the Chicago Tribune.
Consumer safety regulators sounded the alarm about a range of products in 2023, including several geared to kids.
Walmart sold magnetic ball sets online until from February 2022 through April 2023, notice by federal safety regulator says.
Bed Bath & Beyond stores disappeared in 2023, with store closures up 80% across the U.S. Still, more stores opened than closed.
BlendJet has received dozens of reports of injuries from portable blenders sold between October 2020 and November 2023.
Chick-fil-A's policy of closing one day a week doesn't work for truckers and travelers, according to a new bill in New York.
Pizza Hut franchisees in California plan to lay off delivery drivers; DoorDash is raising fees for orders in New York City.
The number of children employed illegally in the U.S. is soaring, Labor Department figures show. Sometimes that work kills them.
Once worth $2.5 billion, the former high-flying startup had pitched itself as a means of helping major cities go green.
Mortgage rates are edging down from their highest level in 23 years as inflation around the U.S. continues to cool.
Pharmacy chain employees harassed and embarrassed customers erroneously flagged by store's AI surveillance technology as repeat shoplifters.
Chiquita Brands subsidiary also produced salad mixes that sickened more than 1,200 in outbreaks in 2018 and 2020, CDC says.
Simmons Foods is recalling chicken products that were sold by retailers including Kroger, Publix, Target and Walmart.
Americans likely to see a gradual thawing of the housing market in 2024, said Freddie Mac's chief economist.
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
Retailing giants move amid calls for a nationwide ban on the products hazardous to young kids and potentially deadly if swallowed.